Rockwell Medical Technologies (RMTI) Reports In-Line Q2 Revenue
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $5.36 +874.55%
EPS Growth %: -200.0%
Financial Fact:
Net Income (Loss): -4.56M
Today's EPS Names:
CRMT, FOMI, FLES, More
EPS Growth %: -200.0%
Financial Fact:
Net Income (Loss): -4.56M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Rockwell Medical Technologies (NASDAQ: RMTI) reported Q2 EPS of ($0.24), may not compare to the analyst estimate of ($0.13). Revenue for the quarter came in at $14.9 million versus the consensus estimate of $14.9 million.
For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- Belden completes acquisition of Ruckus Networks from Vistance
- General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
